400
Participants
Start Date
April 5, 2023
Primary Completion Date
October 8, 2024
Study Completion Date
October 8, 2024
BLI5100
Patients will take BLI5100 once daily, orally, for up to 29 weeks.
Research Site 49, New York
Research Site 28, Hartsdale
Research Site 07, Great Neck
Research Site 35, Brooklyn
Research Site 40, Rochester
Research Site 75, Fayetteville
Research Site 59, Sandy Springs
Research Site 23, Maitland
Research Site 46, Viera
Research Site 42, Miami Lakes
Research Site 108, Cooper City
Research Site 78, Homestead
Research Site 38, Miami
Research Site 43, Miami
Research Site 67, Miami
Research Site 05, Palmetto Bay
Research Site 91, Doral
Research Site 92, Miami
Research Site 71, Miami
Research Site 11, Sunrise
Research Site 17, New Port Richey
Research Site 90, Ocoee
Research Site 24, Huntsville
Research Site 60, Nashville
Research Site 103, Nashville
Research Site 20, Columbus
Research Site 88, Columbus
Research Site 109, Mentor
Research Site 110, Westlake
Research Site 01, Gurnee
Research Site 02, Oak Lawn
Research Site 111, Chesterfield
Research Site 48, Metairie
Research Site 12, Marrero
Research Site 34, New Orleans
Research Site 45, Houma
Research Site 117, North Little Rock
Research Site 87, Little Rock
Research Site 29, Lewisville
Research Site 99, Forney
Research Site 30, Red Oak
Research Site 98, Dallas
Research Site 100, Bellaire
Research Site 32, Pearland
Research Site 22, San Antonio
Research Site 26, San Antonio
Research Site 21, San Antonio
Research Site 65, Sandy City
Research Site 16, South Ogden
Research Site 62, Phoenix
Research Site 27, Tucson
Research Site 06, Las Vegas
Research Site 64, Reno
Research Site 72, Los Angeles
Research Site 54, Los Angeles
Research Site 10, Huntington Park
Research Site 94, Chula Vista
Research Site 55, La Mesa
Research Site 13, Santa Ana
Research Site 41, Santa Maria
Lead Sponsor
Braintree Laboratories
INDUSTRY